developer of Cassava's potential Alzheimer's drug cited for 'egregious misconduct'- Science
13/10/2023 12:50
-- Source link: https://bit.ly/3Qg543C
-- Note: Reuters has not verified this story and does not
vouch for its accuracy
((Bengaluru newsroom, globalnewsmonitoring@thomsonreuters.com))
Recent news on Filana Therapeutics
See all newsCassava Sciences says US DOJ has closed investigation into company (updated)
Cassava Sciences rises after US DOJ closes probe into company
Cassava Sciences says US DOJ has closed investigation into company
Brief: Cassava Announces Agreement To Settle Securities Class Action Litigation
Brief: Cassava Sciences Inc - On Dec 15, FDA Places Full Clinical Hold On Cassava's Trial - SEC Filing